Endothelin-1 is a mediator of intimal hyperplasia in organ culture of human saphenous vein

British Journal of Surgery

Volumn 84, Issue 4, 1997, Pages 499-503

  Masood, I ^a   Porter, K E ^a   London, N J M ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST;

ARTERY INTIMA PROLIFERATION; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HYPERPLASIA; IN VITRO STUDY; ORGAN CULTURE; PRIORITY JOURNAL; SAPHENOUS VEIN; SMOOTH MUSCLE FIBER; VASOCONSTRICTION; VEIN GRAFT;

EID: 0030944372     PISSN: 00071323     EISSN: None     Source Type: Journal    
DOI: 10.1002/bjs.1800840418     Document Type: Article

References (33)

1. Varty K, Allen KE, Bell PRF, London NJM. Infrainguinal vein graft stenosis. Br J Surg 1993; 80: 825-33.
2. Haudenschild CC. Morphology of intimal hyperplasia. J Vasc Surg 1989; 10: 591.
3. Sayers RD, Jones L, Varty K et al. The histopathology of infrainguinal vein graft stenoses. Eur J Vasc Surg 1993; 7: 21-5.
4. Yanagisawa M, Kurihara H, Kimura S et al. A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988; 332: 411-15.
5. Bobik A, Grooms A, Millar JA, Grinpukel S. Growth factor activity of endothelin on vascular smooth muscle. Am J Physiol 1990; 258: C408-15.
6. Eguchi S, Hirata Y, Ihara M, Yano M, Marumo F. A novel ETA antagonist (BQ-123) inhibits endothelin-1-induced phosphoinositide breakdown and DNA synthesis in rat vascular smooth muscle cells. FEBS Lett 1992; 302: 243-6.
7. Hirata Y, Takagi Y, Fukuda Y, Marumo F. Endothelin is a potent mitogen for rat vascular smooth muscle cells. Atherosclerosis 1989; 78: 225-8.
8. Komuro I, Kurihara H, Sugiyama T, Yoshizumi M, Takaku F, Yazaki Y. Endothelin stimulates c-fos and c-myc expression and proliferation of vascular smooth muscle cells. FEBS Lett 1988; 238: 249-52.
9. Douglas SA, Ohlstein EH. Endothelin-1 promotes neointima formation after balloon angioplasty in the rat. J Cardiovasc Pharmacol 1993; 22(Suppl 8): S371-3.
10. Trachtenberg JD, Sun S, Choi ET, Callow AD, Ryan US. Effect of endothelin-1 infusion on the development of intimal hyperplasia after balloon catheter injury. J Cardiovasc Parmacol 1993; 22(Suppl 8): S355-9.
11. Douglas SA, Louden C, Vickery Clark LM et al. A role for endogenous endothelin-1 in neointimal formation after rat carotid artery balloon angioplasty. Protective effects of the novel nonpeptide endothelin receptor antagonist SB209670. Circ Res 1994; 75: 190-7.
12. Soyombo AA, Angelini GD, Bryan AJ, Jasani B, Newby AC. Intimal proliferation in an organ culture of human saphenous vein. Am J Pathol 1990; 137: 1401-10.
13. Park TC, Harker CT, Edwards JM, Moneta GL, Taylor LM Jr, Porter JM. Human saphenous vein grafts explanted from the arterial circulation demonstrate altered smooth-muscle and endothelial responses. J Vasc Surg 1993; 18: 61-9.
14. Ferrell M, Fuster V, Gold HK, Chesebro JH. A dilemma for the 1990s. Choosing appropriate experimental animal model for the prevention of restenosis. Circulation 1992; 85: 1630-1.
15. Davies MG, Klyachkin ML, Kim JH, Hagen P-O. Endothelin and vein bypass grafts in experimental atherosclerosis. J Cardiovasc Pharmacol 1993; 22(Suppl 8): S348-51.
16. Predel G-H, Yang Z, von Segesser L, Turina M, Buhler FR, Luscher TF. Implications of pulsatile stretch on growth of saphenous vein and mammary artery smooth muscle. Lancet 1992; 340: 878-9.
17. Yang ZH, Stulz P, von Segesser L, Bauer E, Turina M, Luscher TF. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991; 337: 939-43.
18. Allen KE, Varty K, Jones L, Sayers RD, Bell PRF, London NJM. Human venous endothelium can promote intimal hyperplasia in a paracrine manner. J Vasc Surg 1994; 19: 577-84.
19. Chan P, Munro E, Patel M et al. Cellular biology of human intimal hyperplastic stenosis. Eur J Vasc Surg 1993; 7: 129-35.
20. Munro E, Patel M, Chan P et al. Growth inhibition of human vascular smooth muscle cells by fenofibrate: a possible therapy for restenosis. Cardiovasc Res 1994; 28: 615-20.
21. Miller RJ. An elastin stain. Med Lab Tech 1971; 28: 148-54.
22. Wagner OF, Christ G, Wojta J et al. Polar secretion of endothelin-1 by cultured endothelial cells. J Biol Chem 1992; 267: 16066-8.
23. Lerman A, Edwards BS, Hallett JW, Heublein DM, Sandberg SM, Burnett JC Jr. Circulating and tissue endothelin immunoreactivity in advanced atherosclerosis. N Engl J Med 1991; 325: 997-1001.
24. Winkles JA, Alberts GF, Brogi E, Libby P. Endothelin-1 and endothelin receptor mRNA expression in normal and atherosclerotic human arteries. Biochem Biophys Res Commun 1993; 191: 1081-8.
25. Zeiher AM, Goebel H, Schachinger V, Ihling C. Tissue endothelin-1 immunoreactivity in the active coronary atherosclerotic plaque. A clue to the mechanism of increased vasoreactivity of the culprit lesion in unstable angina. Circulation 1995; 91: 941-7.
26. Tahara A, Kohno M, Yanagi S et al. Circulating immunoreactive endothelin in patients undergoing percutaneous transluminal coronary angioplasty. Metabolism 1991; 40: 1235-7.
27. Tokunaga O, Fan J, Watanabe T, Kobayashi M, Kumazaki T, Mitsui Y. Endothelin. Immunohistologic localization in aorta and biosynthesis by cultured human aortic endothelial cells. Lab Invest 1992; 67: 210-17.
28. Bonin PD, Leadley RJ Jr, Erickson LA. Growth factor-induced modulation of endothelin-1 binding to human smooth-muscle cells. J Cardiovasc Pharmacol 1993; 22(Suppl 8): S125-7.
29. Cristiani C, Volpi D, Landonio A, Bertolero F. Endothelin-1 selective binding sites are downregulated by transforming growth factor-beta and upregulated by basic fibroblast growth factor in a vascular muscle-derived cell line. J Cardiovasc Pharmacol 1993; 23: 988-94.
30. Weissberg PL, Witchell C, Davenport AP, Hesketh TR, Metcalfe JC. The endothelin peptides ET-1, ET-2, ET-3 and sarafotoxin S6b are co-mitogenic with platelet-derived growth factor for vascular smooth muscle cells. Atherosclerosis 1990; 85: 257-62.
31. Mills JL, Bandyk DF, Gahtan V, Esses GE. The origin of infrainguinal vein graft stenoses: a prospective study based on duplex surveillance. J Vasc Surg 1995; 21: 16-22.
32. Sharefkin JB, Diamond SL, Eskin SG, McIntire LV, Dieffenbach CW. Fluid flow decreases preproendothelin mRNA levels and suppresses endothelin-1 peptide release in cultured human endothelial cells. J Vasc Surg 1991; 14: 1-9.
33. Malek A, Izumo S. Physiological fluid shear stress causes downregulation of endothelin-1 mRNA in bovine aortic endothelium. Am J Physiol 1992; 263: C389-96.